Devyser Diagnostics Up 12%, Insider Buyers Are Up 24%

Insiders who bought Devyser Diagnostics AB (publ) (STO:DVYSR) stock in the last 12 months were richly rewarded last week. The company's market value increased by kr231m as a result of the stock's 12% gain over the same period. As a result, the stock they originally bought for kr11.7m is now worth kr14.6m.

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

See our latest analysis for Devyser Diagnostics

Devyser Diagnostics Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by Chairman Mia Arnhult for kr11m worth of shares, at about kr107 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of kr133. Because it occurred at a lower valuation, it doesn't tell us much about whether insiders might find today's price attractive.

In the last twelve months insiders purchased 109.95k shares for kr12m. But insiders sold 55.00k shares worth kr5.9m. Overall, Devyser Diagnostics insiders were net buyers during the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying.

Insider Ownership

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Devyser Diagnostics insiders own about kr829m worth of shares. That equates to 38% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

What Might The Insider Transactions At Devyser Diagnostics Tell Us?

It doesn't really mean much that no insider has traded Devyser Diagnostics shares in the last quarter. On a brighter note, the transactions over the last year are encouraging. It would be great to see more insider buying, but overall it seems like Devyser Diagnostics insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

Of course Devyser Diagnostics may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.